Online citations, reference lists, and bibliographies.

Cardiac Glycosides And Anticancer Activity

Yuan Hsu Lin, Dapeng Chen, Li Wang, Dong-mei Ye
Published 2013 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/J.BBCAN.2007.06.002
Cardiotonic steroids on the road to anti-cancer therapy.
T. Mijatovic (2007)
10.1371/journal.pone.0008292
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
A. Perne (2009)
10.1002/(SICI)1520-6823(1998)6:3<109::AID-ROI1>3.0.CO;2-1
Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines.
F. Verheye-Dua (1998)
10.1016/J.CRITREVONC.2005.10.005
p53 as a target for anti-cancer drug development.
B. Bouchet (2006)
10.1073/PNAS.0504097102
Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor
Qingfeng Yang (2005)
10.1124/MI.3.3.157
Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function.
Z. Xie (2003)
10.1016/S0079-6603(00)64006-0
Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
J. M. Fortune (2000)
10.1186/1471-2407-1-11
Digitoxin medication and cancer; case control and internal dose-response studies
J. Haux (2001)
10.1016/0092-8674(86)90346-6
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
R. Sen (1986)
10.1081/CNV-120002156
DNA Topoisomerase II as a Target for Cancer Chemotherapy
J. Walker (2002)
10.1158/0008-5472.CAN-05-3544
Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
S. Frese (2006)
Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
S. Manna (2000)
10.1016/S0140-6736(79)90996-6
CARDIAC GLYCOSIDES AND BREAST CANCER
B. Stenkvist (1979)
10.1158/0008-5472.CAN-08-2530
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.
Craig D. Simpson (2009)
10.1007/s10875-006-9028-0
RETRACTED ARTICLE: Oleandrin-Mediated Expression of Fas Potentiates Apoptosis in Tumor Cells
Yashin Sreenivasan (2006)
10.1124/mi.8.1.8
Cardiac glycosides as novel cancer therapeutic agents.
R. Newman (2008)
10.1016/J.MOLIMM.2006.11.009
Oleandrin induces apoptosis in human, but not in murine cells: dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity.
Pongali B. Raghavendra (2007)
10.1073/pnas.0712270105
Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels
N. Arispe (2008)
10.1074/JBC.M002951200
Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase.
M. Haas (2000)
10.1167/iovs.08-3158
Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.
C. Antczak (2009)
10.1006/abbi.1994.1136
Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate.
W. O'Brien (1994)
10.1158/1078-0432.CCR-11-1389
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications.
R. Biggar (2012)
10.1158/0008-5472.CAN-09-0891
Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition.
Z. Wang (2009)
10.1021/ML100219D
Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell.
H. Wang (2011)
10.1158/1078-0432.CCR-08-0706
High-Throughput Screening Identifies Cardiac Glycosides as Potent Inhibitors of Human Tissue Kallikrein Expression: Implications for Cancer Therapies
I. Prassas (2008)
10.1186/bcr2205
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study
T. Ahern (2008)
Letter: Von Wollebrand's disease.
Graham Jb (1974)
10.3892/OR.6.3.493
Is digitalis a therapy for breast carcinoma?
B. Stenkvist (1999)
10.1016/J.BCP.2003.07.010
Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide.
Yashin Sreenivasan (2003)
10.1038/nrc1691
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
W. Kaelin (2005)
10.1248/BPB.29.1493
Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
K. Bielawski (2006)
10.1186/2162-3619-1-4
Digitoxin and its analogs as novel cancer therapeutics
Hosam A. Elbaz (2012)
10.1016/S0014-5793(04)00292-3
Up‐regulation of Na+,K+‐ATPase α3‐isoform and down‐regulation of the α1‐isoform in human colorectal cancer
H. Sakai (2004)
10.1158/1535-7163.MCT-08-1085
Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets
P. Yang (2009)



Semantic Scholar Logo Some data provided by SemanticScholar